AAPP Announces Research Award Recipients Presented at 2025 AAPP Annual Meeting

Abstracts Committee Chair Ijeoma Onyema, PharmD, BCPP, is pleased to recognize the 2025 AAPP Research and Practice Award winners and finalists. Announced April 28 during AAPP’s 28^th Annual Meeting, these awards recognize excellence in investigators presenting abstracts at the AAPP Annual Meeting. Award finalists presented platform presentations and displayed their posters during the meeting. Research and Practice Awards are sponsored by the AAPP Foundation.

Award Winners

Therapeutic Case Report Award

• Leigh Anne Nelson, PharmD, BCPP, FAAPP, Professor, University of Missouri-Kansas City School of Pharmacy, Kansas City, MO
  Clozapine-Induced Eosinopenia in Patients with Treatment-Resistant Schizophrenia: Case Series and Literature Review

Innovative Practices Award

• Harrison Ferro, PharmD, BCPP, Mental Health Clinical Pharmacist Practitioner, Wilkes-Barre Veterans Affairs Medical Center, Margate, FL
  Impact of a Pharmacy Mental Health Practitioner on an Inpatient Psychiatry Consultation Liaison Service

Original Research Award

• Mackenzie Pierce, PHarmD, BCPS, BCPP, Senior Pharmacist Behavioral Health, UC Davis Health, Sacramento, CA
  Psychiatric Pharmacist Impact on Long-Acting Injectable Antipsychotic Utilization

Research Trainee Award

• Cody Thomas, PharmD, PGY-2 Psychiatric Pharmacy Resident, McLean Hospital, Belmont, MA
  Evaluation of Paliperidone Palmitate Loading Doses in Adult Patients with Reduced versus Normal Renal Function at a Stand-Alone Psychiatric Hospital

Health Equity Award

• Kaitlin Grout, PharmD, PGY-2 Psychiatric Pharmacy Resident, Ralph H Johnson VAMC, Charleston, SC
  Impact of Social Determinants of Health on Escalation to Antipsychotic Polypharmacy in Outpatient Mental Health Clinics

Additional Award Finalists

Original Research Award

• Andrew Hean, PharmD, Assistant Professor of Pharmacy Practice and Administration, Western University of Health Sciences, Pomona, CA
  Potential Inpatient Cost-Savings Using Subcutaneous Risperidone ER Versus Paliperidone Palmitate Based on Prescribing Trends of Oral Risperidone

Research Trainee Award

• Megan Mizusawa, PharmD, PGY-2 Psychiatric Pharmacy Resident, Michael E. DeBakey VA Medical Center, Houston, TX
  Retrospective Study of Neuropsychiatric Hospitalizations in Patients Receiving Montelukast vs. Loratadine for Allergic Rhinitis in a Veterans Affairs Population

Health Equity Award

• Chandler Chapman, Student, University of North Carolina Eshelman School of Pharmacy Carrboro, NC
  Evaluating the Administration of One-time Order Intramuscular Antipsychotics Amongst Different Racial Groups within Adult Inpatient Psychiatric Units